Assembly Biosciences Inc expected to post a loss of 47  cents a share - Earnings Preview

Assembly Biosciences

02/05/2022 18:00

* Assembly Biosciences Inc  ASMB.OQ   ASMB.O  is expected
to show
no change in quarterly revenue when it reports  results on May 4
(estimated). 
    * ​Refinitiv's mean analyst estimate for Assembly
Biosciences Inc
is for a loss of 47 cents per share. For the same quarter last
year, the company reported a loss of 69 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Assembly
Biosciences Inc is $12​, above​ its last closing price of $1.76.
​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.51       -0.48      -0.38     Beat    20.4
 Sep. 30 2021  -0.55       -0.56      -0.41     Beat    26.6
 Jun. 30 2021  -0.65       -0.66      -0.55     Beat    16.2​
 Mar. 31 2021  -0.78       -0.79      -0.69     Beat    12.2
 ​​Dec.        -0.90       -0.90      -0.96     Missed  -6.2
 31 2020                                                
 Sep. 30 2020  -0.73       -0.75      -0.09     Beat    88​
 Jun. 30 2020  0.24        -0.03      0.19      Beat    733.3
 Mar. 31 2020  -1.00       -0.98      -0.76     Beat    22.3
 This summary was machine generated May 2 at 17:00 GMT.  All
figures in US dollars  unless otherwise stated